Show simple item record

dc.contributor.authorBreedvelt, JJF
dc.contributor.authorWarren, FCW
dc.contributor.authorBrouwer, MEB
dc.contributor.authorKaryotaki, E
dc.contributor.authorKuyken, W
dc.contributor.authorCuijpers, P
dc.contributor.authorVan Oppen, PV
dc.contributor.authorGilbody, S
dc.contributor.authorBockting, CLH
dc.date.accessioned2020-08-12T09:23:23Z
dc.date.issued2019-02-13
dc.description.abstractPsychological interventions and antidepressant medication can be effective interventions to prevent depressive relapse for patients currently in remission of depression. Less is known about overall factors that predict or moderate treatment response for patients receiving a psychological intervention for recurrent depression. This is a protocol for an individual participant data (IPD) meta-analysis which aims to assess predictors and moderators of relapse or recurrence for patients currently in remission from depression. Methods and analysis Searches of PubMed, PsycINFO, Embase and Cochrane Central Register of Controlled Trials were completed on 13 October 2019. Study extractions and risk of bias assessments have been completed. Study authors will be asked to contribute IPD. Standard aggregate meta-analysis and IPD analysis will be conducted, and the outcomes will be compared with assess whether results differ between studies supplying data and those that did not. IPD files of individual data will be merged and variables homogenised where possible for consistency. IPD will be analysed via Cox regression and one and two-stage analyses will be conducted. Ethics and dissemination The results will be published in peer review journals and shared in a policy briefing as well as accessible formats and shared with a range of stakeholders. The results will inform patients and clinicians and researchers about our current understanding of more personalised ways to prevent a depressive relapse. No local ethics approval was necessary following consultation with the legal department. Guidance on patient data storage and management will be adhered to. PROSPERO registration number CRD42019127844.en_GB
dc.description.sponsorshipAmsterdam Public Health Institute Collaborativeen_GB
dc.identifier.citationVol. 10: e034158en_GB
dc.identifier.doi10.1136/bmjopen-2019-034158
dc.identifier.grantnumber2018
dc.identifier.urihttp://hdl.handle.net/10871/122428
dc.language.isoenen_GB
dc.publisherBMJ Publishing Groupen_GB
dc.rights© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.en_GB
dc.titleIndividual participant data (IPD) meta-analysis of psychological relapse prevention interventions versus control for patients in remission from depression: A protocolen_GB
dc.typeArticleen_GB
dc.date.available2020-08-12T09:23:23Z
dc.identifier.issn2044-6055
dc.descriptionThis is the final version. Available from the publisher via the DOI in this record.en_GB
dc.identifier.journalBMJ Openen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2020-02-13
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2020-02-13
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-08-12T09:19:17Z
refterms.versionFCDVoR
refterms.dateFOA2020-08-12T09:23:28Z
refterms.panelAen_GB
refterms.depositExceptionpublishedGoldOA
refterms.depositExceptionExplanationhttps://doi.org/10.1136/bmjopen-2019-034158


Files in this item

This item appears in the following Collection(s)

Show simple item record

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's licence is described as © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.